<div id="readability-page-1">11:03 AM EST, 11/26/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were surging higher late Wednesday morning, rising 1.25% to 1,614.11 on the S&amp;P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical companies Novo Nordisk ( NVO ) and Ascendis Pharma ( ASND ) , which rose 3.5% and 1.8%, respectively. They were followed by biopharmaceutical company DBV Technologies ( DBVT ) and lender Banco Santander (SAN), which were up 1.7% and 1.6%, respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and brewing company Anheuser-Busch InBev ( BUD ) , which fell 4.6% and 1%, respectively. They were followed by biotech firm Evaxion ( EVAX ) and pharmaceutical company Sanofi (SNY), which were off 0.9% each.From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and NuCana ( NCNA ) , which increased 5.5% and 3.7%, respectively. They were followed by lenders Barclays ( BCS ) and Lloyds Banking Group ( LYG ) , which advanced 3.2% each.The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Bicycle Therapeutics ( BCYC ) , which dropped 4.3% and 1.6%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and alcoholic beverage company Diageo ( DEO ) , which lost 0.8% and 0.5%, respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

Ascendis制药

诺和诺德公司

在美国交易的欧洲股票以 ADR 形式在周三大幅上涨，标准普尔欧洲精选 ADR 指数上涨 1.25%，达到 1,614.11。诺和诺德公司和 Ascendis 制药是显著的涨幅股，而 Cellectis 和安海斯布希英博则领跌。从英国和爱尔兰来看，Akari Therapeutics 和 NuCana 实现了显著的涨幅，而 Autolus Therapeutics 和 Bicycle Therapeutics 则出现了下跌

欧洲股票作为美国存托凭证在美国交易，周三交易中大幅上涨